Sidney Lane, PhD, Joins Pittsburgh-Based Contract Research Organization, Clinical Research Strategies, LLC as Clinical and Regulatory Affairs Project Lead

Pittsburgh, PA – October 26, 2023. Clinical Research Strategies, LLC (“CRS”), a Pittsburgh-area-based, US-owned and operated contract research organization (CRO) and executive management consultancy for the life sciences industry is pleased to announce the addition of Sidney Lane, PhD, Clinical and Regulatory Affairs Project Lead, to the firm. Dr. Lane earned a doctorate in Microbiology and Immunology from the University of Pittsburgh, School of Medicine, conducting extensive research on immune dysfunction and host-microbe interactions during polymicrobial respiratory infections in the laboratory of Dr. Jennifer Bomberger, PhD.

Sidney Lane, PhD

Photo by Jen Worley

Sidney’s research led to multiple peer-reviewed publications and fellowships, including an appointment as a TL1 Clinical and Translational Sciences Fellow. In this role, Sidney expanded her clinical research knowledge through coursework and a personalized training program, allowing her to grow her passion for life sciences research translation. Following her time as a TL1 Fellow, Sidney joined the CRS team as the inaugural intern in the newly established partnership between CRS and the University of Pittsburgh. Outside of the workplace, Sidney loves to play with her dog and enjoys yoga, bouldering, and staying up-to-date on her favorite home renovation shows.

“Sidney is a rare talent who proved her worth toward full-time work after a successful internship with us and after such a short period of time,” says Alethea Wieland, CRS President and Founder. CEO, David Link, MBA adds, “We are excited for Sidney to start her industry career in our firm after her impressive academic pursuits and recognize how early in her career she is poised for exponential growth in life sciences.”

About Clinical Research Strategies, LLC:

CRS is a specialty CRO and executive management consulting firm that fits-for-purpose veteran life sciences executives, attorneys, regulatory scientists and strategists, clinical operations, project management, quality assurance engineers, and sales and marketing teams to take on the biggest challenges for start-up, mid-sized, and large life sciences companies, many of whom are developing novel, first-in-class drugs, biologics, diagnostics and medical devices, or software as a medical device (SaMD). Service areas are clinical trials, Functional Service Provider (FSP) models, selection and management of CROs, regulatory compliance strategy and submissions, QMS, EU MDR and GDPR, rescue trials, TMF, risk mitigation and remediation, training high-performing teams, staffing solutions, and decentralized trials.

Indications represented are precision medicine, immuno-oncology, central nervous system, infectious diseases, respiratory diseases, orthopedics, de novo devices, digital health and mobile apps, reproductive health, regenerative medicine, cardiology, major depressive disorder, opioid-sparing pain, cannabis, radiology, and critical care. CRS is a qualified service provider for federal grants.

CRS is an inclusive employer and does not discriminate in employment on the basis of race, color, religion, sex, gender identity, national origin, political affiliation, sexual orientation, marital status, disability, genetic information, age, education, membership in an employee organization, parental status, military service, or other non-merit factor. CRS does not tolerate censorship, surveillance, bullying, intimidation, retaliation, discrimination, or harassment of any kind.

# # #

Media Contact:
Ron MacDonald
Step2 Branding and Design
+1 724.814.4067

Alethea Wieland, President and Founder
Clinical Research Strategies, LLC
+1 724.272.1245


Download this press release as a PDF.

Share This